Push Forward Clinical Management of Hematological Toxicity due to Lenalidomide Overexposure: Model‐Informed Precision Dosing for Chinese Population With Renal Insufficiency

Documenti analoghi

• Precision Medicine in Oncology: Imatinib Dosing in the Obese Cancer Population Using Virtual Clinical Trials
  di: Khairulanwar Burhanuddin, et al.
  Pubblicazione: (2025)
• Model‐Informed Precision Dosing of Infliximab in Korean Inflammatory Bowel Disease Patients: External Validation of Population Pharmacokinetic Models
  di: Yoonjin Kim, et al.
  Pubblicazione: (2025)
• Pharmacokinetic Model‐Informed Precision Dosing of Natalizumab in Multiple Sclerosis
  di: Stefan P. H. van den Berg, et al.
  Pubblicazione: (2025)
• A Population Pharmacokinetic Model to Inform Extension of the Eteplirsen Dosing Regimen Across the Broad DMD Population
  di: Yogesh Patel, et al.
  Pubblicazione: (2025)
• Numerical Verification of Tucuxi, a Promising Bayesian Adaptation Tool for Model‐Informed Precision Dosing
  di: Anne Ravix, et al.
  Pubblicazione: (2025)